Returns Chart

Key Stats

Net Expense Ratio Total Assets Under Management Weighted Average Dividend Yield Turnover Ratio (Generic)
0.79% 984.42M 2.11% 31.00%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized Total Returns Since Inception (Daily) Max Drawdown (Since Inception)
-234.39M 12.67%

Basic Info

Investment Strategy
The Fund seeks long-term growth of capital by investing at least 65% of its assets in common stocks of domestic companies. The Fund invests in companies having a minimum market capitalization of $250 million at the time of purchase, and seeks to maintain a minimum average weighted market capitalization of $5 billion.
General
Security Type Insurance Fund
Equity Style Multi Cap Value
Broad Asset Class US Equity
Broad Category Equity
Global Peer Group Equity US
Peer Group Multi-Cap Value Funds
Global Macro Equity North America
US Macro Multi-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Growth & Income Funds
Fund Owner Firm Name Jackson
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Net Fund Flows Versus Peer Group

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: 72
-4.456B Peer Group Low
860.90M Peer Group High
1 Year
% Rank: 79
-234.39M
-8.445B Peer Group Low
7.415B Peer Group High
3 Months
% Rank: 76
-3.789B Peer Group Low
3.488B Peer Group High
3 Years
% Rank: 86
-13.20B Peer Group Low
9.077B Peer Group High
6 Months
% Rank: 81
-4.588B Peer Group Low
6.076B Peer Group High
5 Years
% Rank: 84
-13.51B Peer Group Low
40.45B Peer Group High
YTD
% Rank: 73
-4.456B Peer Group Low
860.90M Peer Group High
10 Years
% Rank: 78
-29.76B Peer Group Low
73.29B Peer Group High
Date Unavailable

Performance Versus Peer Group

 
20%
15%
10%
5%
0
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
Peer Group Rtn. (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
% Rank in Peer Group (NAV)
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
View Performance Versus Peer Group
Start Trial

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
27.51%
1.52%
26.98%
-4.84%
9.21%
10.88%
14.67%
2.97%
31.49%
18.40%
28.71%
-18.11%
26.29%
25.02%
17.88%
1.15%
23.78%
-2.90%
30.93%
-6.66%
11.19%
16.74%
17.41%
4.15%
21.71%
-4.72%
25.04%
1.52%
7.08%
4.84%
11.14%
5.23%
24.63%
4.15%
25.69%
-5.48%
14.46%
17.16%
15.92%
4.05%
23.51%
0.53%
21.92%
-5.63%
12.56%
12.84%
18.21%
4.25%
As of February 04, 2026.

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (2-3-26) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings 67
Stock
Weighted Average PE Ratio 23.79
Weighted Average Price to Sales Ratio 3.991
Weighted Average Price to Book Ratio 5.242
Weighted Median ROE 26.26%
Weighted Median ROA 7.51%
ROI (TTM) 13.17%
Return on Investment (TTM) 13.17%
Earning Yield 0.0505
LT Debt / Shareholders Equity 0.9561
Number of Equity Holdings 64
As of December 31, 2025

Growth Metrics

EPS Growth (1Y) 13.80%
EPS Growth (3Y) 5.84%
EPS Growth (5Y) 10.82%
Sales Growth (1Y) 5.75%
Sales Growth (3Y) 6.02%
Sales Growth (5Y) 8.27%
Sales per Share Growth (1Y) 7.23%
Sales per Share Growth (3Y) 7.42%
Operating Cash Flow - Growth Rate (3Y) 5.53%
As of December 31, 2025

Asset Allocation

As of December 31, 2025.
Type % Net
Cash 0.32%
Stock 99.30%
Bond 0.43%
Convertible 0.00%
Preferred 0.00%
Other -0.05%
View Asset Allocation
Start Trial

Top 10 Holdings

Name % Weight Price % Change
Alphabet, Inc. 4.87% 333.34 -2.16%
JPMorgan Chase & Co. 4.08% 317.75 0.92%
Johnson & Johnson 2.97% 234.45 0.58%
Merck & Co., Inc. 2.54% 118.34 2.16%
UnitedHealth Group, Inc. 2.20% 275.74 -2.97%
Cisco Systems, Inc. 2.08% 81.16 -2.34%
PACCAR, Inc. 1.79% 128.82 0.72%
Elevance Health, Inc. 1.78% 340.54 0.56%
Accenture Plc 1.77% 241.68 0.20%
Pfizer Inc. 1.77% 26.77 3.88%

Fees & Availability

Fees
Actual 12B-1 Fee 0.30%
Actual Management Fee 0.38%
Administration Fee 757.8K%
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product Yes
Available for RRSP No
Purchase Details
Open to New Investors Yes
Minimum Initial Investment 0.00 None
Minimum Subsequent Investment 0.00 None

Basic Info

Investment Strategy
The Fund seeks long-term growth of capital by investing at least 65% of its assets in common stocks of domestic companies. The Fund invests in companies having a minimum market capitalization of $250 million at the time of purchase, and seeks to maintain a minimum average weighted market capitalization of $5 billion.
General
Security Type Insurance Fund
Equity Style Multi Cap Value
Broad Asset Class US Equity
Broad Category Equity
Global Peer Group Equity US
Peer Group Multi-Cap Value Funds
Global Macro Equity North America
US Macro Multi-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Growth & Income Funds
Fund Owner Firm Name Jackson
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (2-3-26) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings 67
Stock
Weighted Average PE Ratio 23.79
Weighted Average Price to Sales Ratio 3.991
Weighted Average Price to Book Ratio 5.242
Weighted Median ROE 26.26%
Weighted Median ROA 7.51%
ROI (TTM) 13.17%
Return on Investment (TTM) 13.17%
Earning Yield 0.0505
LT Debt / Shareholders Equity 0.9561
Number of Equity Holdings 64
As of December 31, 2025

Growth Metrics

EPS Growth (1Y) 13.80%
EPS Growth (3Y) 5.84%
EPS Growth (5Y) 10.82%
Sales Growth (1Y) 5.75%
Sales Growth (3Y) 6.02%
Sales Growth (5Y) 8.27%
Sales per Share Growth (1Y) 7.23%
Sales per Share Growth (3Y) 7.42%
Operating Cash Flow - Growth Rate (3Y) 5.53%
As of December 31, 2025

Fund Details

Key Dates
Launch Date 9/30/2002
Share Classes
LP40104063 Inst
Attributes
Inverse Fund No
Leveraged Fund --
Currency Hedged Fund --
Socially Responsible Fund No

Top Portfolio Holders

Name % Weight
Portfolio A 5.00%
Portfolio B 3.50%
Portfolio C 2.25%
View Top Portfolio Holders
Start Trial